biotech-365.com

What It Is

Biotech 365 positions itself as a business partner for the healthcare and biotechnology sectors, covering services such as fundraising, licensing partnerships, distribution and commercialization, and startup incubation. It also offers healthcare industry database subscriptions, as well as an AI-powered clinical trial due diligence analytics platform called CliDD Pharmaceuticals. Overall, it is not a traditional general-purpose SaaS product, but rather a combination of “industry database + consulting/deal matchmaking + vertical analytics tool.”

Core Features and Product Format

The database subscription provides access to five categories of resources: Healthcare Investors, Business Angels, Healthcare Companies, Distributors, and CRO/CDMO. Users can filter investors by standard criteria and view information such as investment criteria, websites, and LinkedIn profiles. The database does not allow downloads or copy-pasting; it can only be accessed online, with Airtable used on the backend. The CliDD platform, meanwhile, unifies and standardizes thousands of clinical trial records, supporting search and AI Q&A around endpoints, inclusion/exclusion criteria, study design, competitors, and the regulatory landscape. It is aimed at clinical development, investment due diligence, and strategy teams.

Pricing, Trial, and Payment

Service-based offerings use a success-fee model, with no upfront retainer or fixed fees. The database subscription costs €20/month or €100/year, with automatic renewal. The CliDD platform costs €1000/month and is described as offering unlimited queries. A free Demo is available for the database, while a free demo for CliDD can be arranged by contacting the company. Payment is by credit card only, using WooCommerce and Stripe. After purchase, users typically receive a personal access link and password by email within 24-48 hours.

Pros and Cons

The main advantages are its clear vertical focus on healthcare, covering practical use cases such as fundraising, distribution, licensing, and CRO/CDMO sourcing. The database has a low entry price, and the Demo helps reduce purchase uncertainty. The success-fee service model is also suitable for early-stage companies that are sensitive to cash flow. The downsides are limited disclosure around enterprise-grade SaaS capabilities: there is no visible information on team permissions, APIs, audit logs, security certifications, bulk export, or CRM integrations. Subscription cancellation must be handled by email, ongoing billing periods are non-refundable, and delivery also relies heavily on manual email communication.

Who It’s For and Access from China

Biotech 365 is suitable for biotechnology, pharmaceutical, medical device, diagnostics, and digital health teams seeking overseas fundraising, commercial partnerships, distribution channels, or CRO/CDMO resources. It is also relevant for strategy professionals conducting clinical trial competitive research and protocol optimization. Access conditions from China are not disclosed in the available text, and Stripe credit card payments may be inconvenient for some domestic users. Alternatives to consider include PitchBook, Crunchbase, CB Insights, Citeline/Trialtrove, as well as China-based platforms such as PharmaGO, VCBeat’s data products, and Yaozh Data.